Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1523-1533

  Iizuka, Junko ^a   Katagiri, Yohko ^a   Tada, Norihiro ^c   Murakami, Masaaki ^a   Ikeda, Tohru ^d   Sato, Masahiro ^e   Hirokawa, Katsuiku ^f   Okada, Seiji ^b   Hatano, Masahiko ^b   Tokuhisa, Takeshi ^b   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e TOKAI UNIVERSITY   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; DISEASE ASSOCIATION; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY FORMATION; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, TRANSGENIC; OSTEOPONTIN; PERITONEAL CAVITY; PHOSPHOPROTEINS; SIALOGLYCOPROTEINS; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0032407735     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Blaese RM, Crayson J, and Steinberg AD (1980). Elevated immunoglobulin secreting cells in the blood of patients with active SLE: Correlation of laboratory and clonical assessment of disease activity. Am J Med 69:345-350.
2. Bond A, Hay FC, and Cook A (1988). The relationship between induced and spontaneous autoantibodies in MRL mice: The role of Ly-1 B cells. Immunol 64:325-329.
3. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, and Brown LF (1997). Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 77:103-108.
4. Chambers AF, Behrend EI, Wilson SM, and Denhardt DT (1992). Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH3T3 cells. Anticancer Res 12:43-48.
5. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Craig AM, Smith JH, and Denhardt DT (1989). Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol.13-acetate in mouse epidermis. J Biol Chem 264:9682-9689.
7. Denhardt DV and Guo X (1993). Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
8. Fukuda T, Miki T, Yoshida T, Hatano M, Ohashi K, Hirosawa S, and Tokuhisa T (1995). The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene. Oncogene 11:1657-1663.
9. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, and Almeida M (1998). Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358.
10. Guo X, Zhang YP, Mitchell DA, Denhardt DT, and Chambers AF (1995). Identification of a ras-activated enhancer in the mose osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with metastatic potential. Mol Cell Biol 15:476-487.
11. Hardy RR and Hayakawa K (1994). CD5 B cells, a fetal B cell lineage. Adv Immunol 55:297-339.
12. Hogan B, Constantini F, and Lacy E (1986). Manipulating the mouse embryo. In: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
13. Hu DD, Lin ECK, Kovach NL, Hoyer JR, and Smith JW (1995). A biochemical characterization of the binding of osteopontin to integrins αvb1 and αvb5. J Biol Chem 270:26232-26238.
14. Huang F-P, Feng G-J, Lindop G, Stott DI, and Liew FY (1996). The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/Mp-Ipr/Ipr mice. J Exp Med 183:1447-1459.
15. Inobe M, Aoki N, Linsley PS, Ledbetter JA, Abe R, Murakami M, and Uede T (1996). The role of B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. J Immunol 157:582-588.
16. Izui SP, McConahey PJ, and Dixon FJ (1978). Increased polyactivation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol 121:2213-2219.
17. Kaneko Y, Hirose S, Abe M, Yagita H, Okumura K, and Shirai T (1996). CD40-mediated stimulation of B1 and B2 cells: Implication in autoantibody production in murine lupus. Eur J Immunol 26:3061-3065.
18. Kantor AB and Herzenberg LA (1993). Origin of murine B cell lineages. Annu Rev Immunol 11:501-538.
19. Katagiri Y, Mori K, Hara T, Tanaka K, Murakami M, and Uede T (1995). Functional analysis of the osteopontin molecule. Ann N Y Acad Sci 760:371-374.
20. Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia W-J, Chambers AF, and Uede T (1996). Non-RGD domains of osteopontin promote cell adhesion without involving αv integrins. J Cell Biochem 62:123-131.
21. Kawarabayashi T, Shoji M, Sato M, Sasaki A, Ho L, Eckman CB, Parada CM, Younkin SG, Kobayashi T, Tada N, Matsubara E, Iizuka T, Harigaya Y, Kasai K, and Hirai S (1996). Accumulation of β-amyloid fibrils in pancreas of transgenic mice. Neurobiol Aging 17:215-222.
22. Kendall C, Ionescu-Matiu I, and Dreesman GR (1984). Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 56:329-339.
23. Klinman DM and Steinberg AD (1987a) Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165:1755-1760.
24. Kliman DM and Steinberg AD (1987b) Novel ELISA and ELISA-spot assays used to quantitate B cells and serum antibodies specific for cell and bromelated mouse red blood cell autoantibodies. J Immunul Methods 102:157-164.
25. Lampe MA, Patarca R, Iregui MV, and Cantor H (1991). Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 147:2902-2906.
26. Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, and Atkins RC (1998). De novo glomerular osteopontin expression in rat crescentic glomeruonephritis. Kidney Int 53:136-145.
27. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh DA, and Hruska KA (1991). Recognition of osteopontin and related peptides by an αvβ3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 266: 20369-20374.
28. Monroe JG, Cambier JC, Mody EA, and Pisetsky DS (1985). Hyper-Ia antigen expression on B cells from B6-Ipr/Ipr mice correlates with manifestations of the autoimmune state. Clin Immunol Immununopathol 34:124-129.
29. Mori K, Kobayashi S, Inobe M, Jia W-Y, Tamakoshi M, Miyazaki T, and Uede T (1994). In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-Ipr/Ipr mouse. Autoimmunity 17:49-57.
30. Nakama K, Miyazaki Y, and Nasu M (1998). Immunophenotyping of lymphocytes in the lung interstitium and expression of osteopontin and interleukin-2 mRNAs in two different murine medels of pulmonary fibrosis. Exp Lung Res 24:57-70.
31. Nau GJ, Guilfoile P, Chupp GL, Berman JS, Kim SJ, Kornfeld H, and Yound RA (1997). A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci USA 94:6414-6419.
32. Niwa H, Yamamura K, and Miyazaki J (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200.
33. Oldberg A, Franzen A, and Heinegard D (1986). Cloning and sequnece analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823.
34. Patarca R, Freeman GJ, Singh RP, Wei F-Y, Durfee T, Blattner F, Regnier DC, Kozak CA, Mock BA, Morse HC, Jerrels TR, and Cantor H (1989). Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170:145-161.
35. Patarca R, Saavedra RA, and Cantor H (1993). Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13:225-246.
36. - lymphocytes during the development of murine autoimmune disease. J Exp Med 172:1177-1183.
37. Peng SL, McNiff JM, Madaio MP, Ma J, Owen MJ, Flavell RA, Hayday AC, and Craft J (1997a). αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 158:2464-2470.
38. Peng SL, Moslehi J, and Craft J (1997b). Roles of interferon-γ and interleukin-4 in murine lupus. J Clin Invest 99:1936-1946.
39. Prud'homme GJ, Kono DH, and Theofilopoulos AN (1995). Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 32:495-503.
40. Reik W, Williams G, Barton D, Morris M, Neuberger M, and Surani MA (1987). Provision of the immunoglobulin heavy chain enhancer downstream of a test gene is sufficient to confer lymphoid-specific expression in transgenic mice. Eur J Immunol 17:465-469.
41. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farah-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, and Cheresh DA (1993). Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone. J Biol Chem 268:9901-9907.
42. Takahashi K, Nakamura T, Koyanagi M, Kato K, Hashimoto Y, Yagita H, and Okumura K (1990). A murine very late activation antigen-like extracellular matrix receptor involved in CD2-and lymphocyte function-associated antigen-I-independent killer-target cell interaction. J Immunol 145: 4371-4379.
43. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, and Izui S (1996). Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597-1604.
44. Tominaga A, Takai S, Koyama N, Katoh S, Matsumoto R, Migita M, Hitoshi Y, Hosoya Y, Yamauchi S, Kanai Y, Miyazaki J, Usuku G, Yamamura K, and Takatsu K (1991). Transgenic mice expressing a B cell growth and Differentiation factor gene (Interleukin-5) develop eosinophilia and autoantibody production. J Exp Med 173:429-437.
45. van Ooyen A, van den Berg J, Mantei N, and Weissmann C (1979). Comparison of total sequence of a cloned rabbit β-globin gene and its flanking regions with a homologous mouse sequence. Science 206:337-344.
46. Weichert TR and Schwartz RC (1997). Inductioon of murine CD5 expression by v-H-ras. Immunology 90:30-37.